The APOB Gene Encoding Putative Low Density Lipoprotein Receptor Binding Domain of the ApoB-100 Protein Shows No DNA Polymorphisms

Russian Journal of Genetics

Volumn 32, Issue 2, 1996, Pages 261-263

  Shevtsov, S P ^a  

^a PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842585549     PISSN: 10227954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schonfeld, G., The Genetic Dyslipoproteinemias -Nosology Update 1990, Atherosclerosis, 1990, vol. 81, pp. 81-93.
2. Breslow, J.L., Human Apolipoprotein Molecular Biology and Genetic Variation, Annu. Rev. Biochem., 1985, vol. 54, pp. 699-727.
3. Zannis, V.I., Kardassis, D., and Zanni, E.E., Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes, Adv. Hum. Genet., 1993, vol. 21, pp. 145-319.
4. Munro, J.M. and Cotran, R.S., Biology of Disease, The Pathogenesis of Atherosclerosis: Atherogenesis and Inflamation, Lab. Invest., 1988, vol. 58, pp. 249-261.
5. Ross, R., The Pathogenesis of Atherosclerosis: A Perspective for the 1990s, Nature, 1993, vol. 362, pp. 801-809.
6. Brown, M.S. and Goldstein, J.L., A Receptor-Mediated Pathway for Cholesterol Homeostasis, Science, 1986, vol. 232, pp. 34-47.
7. Smythe, E. and Warren, G., The Mechanism of Receptor-Mediated Endocytosis, Eur. J. Biochem., 1991, vol. 202, pp. 689-699.
8. Hayashi, K., PCR-SSCP: A Method for Detection of Mutations, GATA, 1992, vol. 9, pp. 73-79.
9. Lench, N., Stanier, Ph., and Williamson, R., Lancet, 1988, vol. 18, pp. 1356-1358.
10. Saiki, R.K. et al., Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase, Science, 1988, vol. 239, pp. 487-491.
11. Low, S.W., Grant, S.M., Higuchi, K., et al, Human Liver Apolipoprotein B-100 cDNA: Complete Nucleic Acid and Derived Amino Acid Sequence, Proc. Natl. Acad. Sci. USA, 1986, vol. 83, pp. 8142-8146.
12. Maniatis, T., Fritsch, E.F., and Sambrook, J., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York: Cold Spring Harbor Lab., 1982.
13. Casanova, J.-L. et al., Optimal Conditions for Directly Sequencing Double-Stranded PCR Products with Sequenase, Nucleic Acids Res., 1990, vol. 18, no. 13, p. 4028.
14. Dunning, A.M., Houlston, R., Frostgard, J., et al., Genetic Evidence That the Putative Receptor Binding Domain of Apolipoprotein B (Residues 3130 to 3630) Is Not the Only Region of the Protein Involved in Interaction with the Low Density Lipoprotein Receptor, Biochim. Biophys. Acta., 1991, vol. 1096, pp. 231-237.
15. Deeb, S.S., Failor, R.A., and Brown, B.G., Association of Apolipoprotein B Gene Variants with Plasma apoB and Low Density Lipoprotein (LDL) Cholesterol Levels, Hum. Genet., 1992, vol. 88, pp. 463-470.
16. Avoustin, P., Mostachi, H., Perret, B., et al., A Very Conservative Region of ApoB-100 in the Putative Binding Region to the LDL Receptor in the Toulouse Population, Hum. Genet., 1992, vol. 90, pp. 460-463.
17. Shevtsov, S.P., Kuchinskii, A.P., Dzeranova, N.Ya., et al., Analysis of DNA Polymorphisms of the Genes for Apolipoproteins ApoB and ApoC3 in Patients with Myocardial Infarction, Mol., Mikrobiol. Virusol, 1994, no. 3, pp. 33-36.